Clinical Trials Directory

Trials / Sponsors / TScan Therapeutics, Inc.

TScan Therapeutics, Inc.

Industry · 8 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Long Term Follow-up Study of TScan TCR-T Products
AML, ALL, MDS
—2025-09-09
Active Not RecruitingA Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable)
Head and Neck Cancer, Cervical Cancer, Non-small Cell Carcinoma
Phase 12024-05-06
Active Not RecruitingA Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Sol
Head and Neck Cancer, Cervical Cancer, Non Small Cell Lung Cancer
—2023-06-26
RecruitingA Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune
Autoimmune Diseases, Ulcerative Colitis, Multiple Sclerosis
—2023-01-03
RecruitingA Study of TSC-100 and TSC-101 in AML, ALL and MDS in Patients Undergoing Allogeneic Peripheral Blood Stem Tra
AML, Myelodysplastic Syndromes, ALL, Adult
Phase 12022-11-01
UnknownA Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor
Solid Tumor, Adult
—2021-02-26
WithdrawnTissue Collection to ID TCRs From Renal Clear Cell Carcinoma Patients Responding to Immune Checkpoint Inhibito
Renal Clear Cell Carcinoma
—2020-12-17
CompletedBlood Collection Study From COVID-19 Convalescents Previously Hospitalized to Identify Immunogenic Viral Epito
Identify the Viral Epitopes of Memory CD8 T Cells From Individuals That Have Recovered From SARS-CoV-2 Infection, Determine Which SARS-CoV-2 Proteins Are Frequently Recognized by T Cells in Patients With Varying HLA Types
—2020-04-09